Elevar to Establish 'Neolevar' and to participate in JP Morgan Healthcare (1/6/2020)
- Elevar to participate in JP Morgan Healthcare (2020.1.13 ~ 1.16)
- With Neolevar, HLB will expand its business field by establishing a distribution network of Rivoceranib in early stages in the MENA&INDIA region as well as operating multiple cooperative relationships with Neopharma.
- With demonstrating the efficacy of new drugs and the ability to develop new drugs through Rivoceranib’s global clinical phase 3, Elevar expects many business opportunities through the upcoming conference.
Work may be later than expected, regardless of the company's efforts and will, as in Neolevar, which was expected to be approved by the UAE government in early December. However, what the company has professed has always been and certainly will continue to do so. Please stay informed.
Wishing you a Happy New Year with the hope that you will have many blessings in the year to come.